Physician profile
Steven Liu
NPI 1992918643
$1,506.13
in general payments reported to CMS, 2019-2025
19 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $13.49 · 2021: $21.78 · 2022: $119 · 2023: $354 · 2024: $455 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,119.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $378.68 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $204.24 | 2022-2025 | Dupixent |
| Abbvie INC. | $142.49 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $123.56 | 2024 | |
| Janssen Scientific Affairs, LLC | $122.24 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $111.68 | 2024 | Dupixent |
| Ipsen Biopharmaceuticals, INC | $58.44 | 2023-2025 | Bylvay, Iqirvo |
| Fresenius Kabi USA, LLC | $56.39 | 2022-2023 | Idacio |
| Takeda Pharmaceuticals U.S.A., INC. | $55.73 | 2023-2025 | Gattex, Eohilia |
| Qol Medical, LLC | $53.51 | 2023-2024 | Sucraid, Sucraid |
| Amgen INC. | $44.93 | 2021-2022 | |
| Organon LLC | $36.02 | 2023-2025 | Renflexis, Hadlima |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.77 | 2023 | |
| Biocon Biologics INC | $20.65 | 2024 | Hulio |
| Mirum Pharmaceuticals, INC. | $19.10 | 2023 | Livmarli |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $16.70 | 2025 | Tremfya |
| Ironwood Pharmaceuticals, INC | $14.47 | 2024 | |
| Travere Therapeutics, INC. | $14.27 | 2019-2020 | |
| Allergan, INC. | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.